Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor β/δ Agonist

Simone Naruhn, Wolfgang Meissner, Till Adhikary, Kerstin Kaddatz, Thomas Klein, Bernhard Watzer, Sabine Müller-Brüsselbach and Rolf Müller
Molecular Pharmacology February 2010, 77 (2) 171-184; DOI: https://doi.org/10.1124/mol.109.060541
Simone Naruhn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Meissner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Till Adhikary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerstin Kaddatz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Klein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Watzer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabine Müller-Brüsselbach
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rolf Müller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 77 no. 2 171-184
DOI 
https://doi.org/10.1124/mol.109.060541
PubMed 
19903832

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received August 27, 2009
  • Accepted November 10, 2009
  • Published online January 19, 2010.

Article Versions

  • Earlier version (November 10, 2009 - 09:13).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Simone Naruhn,
  2. Wolfgang Meissner,
  3. Till Adhikary,
  4. Kerstin Kaddatz,
  5. Thomas Klein,
  6. Bernhard Watzer,
  7. Sabine Müller-Brüsselbach and
  8. Rolf Müller
  1. Institute of Molecular Biology and Tumor Research (S.N., W.M., T.A., K.K., S.M.-B., R.M.) and Department of Pediatrics (B.W.), Philipps University, Marburg, Germany; and Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach/Riss, Germany (T.K.)
  1. Address correspondence to:
    Dr. Rolf Müller, Institut für Molekularbiologie und Tumorforschung (IMT), Philipps-Universität Marburg, Emil-Mannkopff-Strasse 2, 35032 Marburg, Germany. E-mail: rmueller{at}imt.uni-marburg.de
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2009 to April 2022

AbstractFullPdf
Nov 2009305
Dec 200929050
Jan 201033316117
Feb 20103952346
Mar 20101432522
Apr 2010972026
May 20101603419
Jun 20101582118
Jul 20101001824
Aug 2010851112
Sep 2010661515
Oct 2010521523
Nov 2010541110
Dec 2010783415
Jan 2011702216
Feb 201116311222
Mar 2011824732
Apr 2011422420
May 2011563116
Jun 2011302031
Jul 2011421618
Aug 2011548028
Sep 2011244328
Oct 2011452225
Nov 2011431823
Dec 2011302427
Jan 2012473533
Feb 2012624928
Mar 2012564325
Apr 2012487519
May 2012482432
Jun 2012522127
Jul 2012342425
Aug 2012502122
Sep 2012492425
Oct 2012352128
Nov 2012551932
Dec 2012402022
Jan 20131066141
Feb 2013482624
Mar 2013511927
Apr 2013471934
May 2013402731
Jun 201328812
Jul 201310814
Aug 2013251110
Sep 2013351515
Oct 2013371515
Nov 2013461111
Dec 20133369
Jan 2014411021
Feb 2014431516
Mar 201430828
Apr 2014201320
May 20142449
Jun 2014341528
Jul 2014181118
Aug 201418917
Sep 2014361721
Oct 2014301314
Nov 201423229
Dec 2014331217
Jan 201528104
Feb 20152567
Mar 201522118
Apr 201539924
May 2015261319
Jun 201518820
Jul 2015331623
Aug 2015381913
Sep 201512812
Oct 2015151110
Nov 201519711
Dec 20152693
Jan 2016471830
Feb 2016571615
Mar 201646513
Apr 201665719
May 201626817
Jun 2016111825
Jul 2016231626
Aug 2016421744
Sep 2016412431
Oct 2016222010
Nov 2016231917
Dec 201633414
Jan 201715220
Feb 201794617
Mar 201776423
Apr 201792414
May 20173509
Jun 201742622
Jul 201763933
Aug 2017142423
Sep 2017111718
Oct 201783116
Nov 2017617313
Dec 2017963714
Jan 2018639220
Feb 20182228114
Mar 20182622921
Apr 2018613014
May 2018913116
Jun 20186559
Jul 201896617
Aug 2018716211
Sep 2018811317
Oct 201856623
Nov 20181314319
Dec 2018814212
Jan 2019105111
Feb 201995420
Mar 20195818
Apr 201934020
May 201942317
Jun 201944520
Jul 201929316
Aug 201950324
Sep 201947319
Oct 201940721
Nov 201942710
Dec 20193118
Jan 20202749
Feb 20203008
Mar 20204216
Apr 20201500
May 20203220
Jun 20201414
Jul 20203002
Aug 2020932
Sep 2020912
Oct 20201875
Nov 20201844
Dec 20201743
Jan 20212945
Feb 20213889
Mar 20212712
Apr 2021311210
May 20214131
Jun 2021742
Jul 20211345
Aug 20211662
Sep 202115911
Oct 20211573
Nov 20213422
Dec 20212931
Jan 20223669
Feb 20222621
Mar 20223367
Apr 20221885

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 77 (2)
Molecular Pharmacology
Vol. 77, Issue 2
1 Feb 2010
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor β/δ Agonist
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor β/δ Agonist

Simone Naruhn, Wolfgang Meissner, Till Adhikary, Kerstin Kaddatz, Thomas Klein, Bernhard Watzer, Sabine Müller-Brüsselbach and Rolf Müller
Molecular Pharmacology February 1, 2010, 77 (2) 171-184; DOI: https://doi.org/10.1124/mol.109.060541

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor β/δ Agonist

Simone Naruhn, Wolfgang Meissner, Till Adhikary, Kerstin Kaddatz, Thomas Klein, Bernhard Watzer, Sabine Müller-Brüsselbach and Rolf Müller
Molecular Pharmacology February 1, 2010, 77 (2) 171-184; DOI: https://doi.org/10.1124/mol.109.060541
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • LYN Kinase and Tyrosine Kinase Inhibitors Regulate OATP1B3
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics